Search research articles
Contact Us
Filters
Showing results (11-20 of 138) with videos related to
Page
of 14
Sort By:
Plos One
|
January 28, 2014
Heparanase interacts with resistin and augments its activity
Daniela Novick, Sara Barak, Neta Ilan, et al.
Human Vaccines & Immunotherapeutics
|
April 8, 2016
Heparanase and cancer progression: New directions, new promises
Gil Arvatz, Marina Weissmann, Neta Ilan, et al.
Current Pharmaceutical Design
|
July 14, 2007
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate
Israel Vlodavsky, Neta Ilan, Annamaria Naggi, et al.
Cancer Research
|
March 27, 2015
Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis
Yelena Mumblat, Ofra Kessler, Neta Ilan, et al.
Biochemical Pharmacology
|
February 26, 2014
The potential of heparanase as a therapeutic target in cancer
Claudio Pisano, Israel Vlodavsky, Neta Ilan, et al.
FEBS Letters
|
April 26, 2005
Heparanase processing by lysosomal/endosomal protein preparation
Esti Cohen, Ruth Atzmon, Israel Vlodavsky, et al.
Trends in Biochemical Sciences
|
September 8, 2009
Heparanase: busy at the cell surface
Liat Fux, Neta Ilan, Ralph D Sanderson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
April 11, 2021
Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma
Yasmin Kayal, Preeti Singh, Inna Naroditsky, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 15, 2024
Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms
Israel Vlodavsky, Maram Hilwi, Yasmin Kayal, et al.
Cell Death & Disease
|
July 25, 2023
Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation
Yasmin Kayal, Uri Barash, Inna Naroditsky, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 138) with videos related to
Sort By:
Page
of 14
Plos One
|
January 28, 2014
Heparanase interacts with resistin and augments its activity
Daniela Novick, Sara Barak, Neta Ilan, et al.
Human Vaccines & Immunotherapeutics
|
April 8, 2016
Heparanase and cancer progression: New directions, new promises
Gil Arvatz, Marina Weissmann, Neta Ilan, et al.
Current Pharmaceutical Design
|
July 14, 2007
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate
Israel Vlodavsky, Neta Ilan, Annamaria Naggi, et al.
Cancer Research
|
March 27, 2015
Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis
Yelena Mumblat, Ofra Kessler, Neta Ilan, et al.
Biochemical Pharmacology
|
February 26, 2014
The potential of heparanase as a therapeutic target in cancer
Claudio Pisano, Israel Vlodavsky, Neta Ilan, et al.
FEBS Letters
|
April 26, 2005
Heparanase processing by lysosomal/endosomal protein preparation
Esti Cohen, Ruth Atzmon, Israel Vlodavsky, et al.
Trends in Biochemical Sciences
|
September 8, 2009
Heparanase: busy at the cell surface
Liat Fux, Neta Ilan, Ralph D Sanderson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
April 11, 2021
Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma
Yasmin Kayal, Preeti Singh, Inna Naroditsky, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 15, 2024
Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms
Israel Vlodavsky, Maram Hilwi, Yasmin Kayal, et al.
Cell Death & Disease
|
July 25, 2023
Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation
Yasmin Kayal, Uri Barash, Inna Naroditsky, et al.
Page
of 14